Trends-in-Medicine has no financial connections with any pharmaceutical or medical device company. The information and opinions expressed have been compiled or arrived at from sources believed to be reliable and in good faith, but no liability is assumed for information contained in this newsletter. Copyright ©2013. No articles may be reproduced without written permission of the publisher.

Archives

Glitazones for Type 2 Diabetes

ELR August 2007 Issue

FDA Highlights Value of Genetics in Dosing of Warfarin and Codeine

FDA Approves Risperdal for Children and Adolescents

FDA Advisory Panel Says Avandia Risky but Should Stay on Market

FDA Advisory Panel Recommeds Restricted Approval of Tysabri for Crohn's Disease

ELR July 2007 Issue

FDA Asking Advisers if Avandia Should Stay on the Market

European Renal Association - European Dialysis and Transplant Association (ERA-EDTA)

ELR June 2007 Issue

European League Against Rheumatism (EULAR)

Contact Lens Solution Update

American Society of Clinical Oncology (ASCO)

American Society of Hypertension (ASH)

EuroPCR

Search

Events Calendar

Categories

Get Adobe Reader

Disclaimer